A prospective trial of the effects of isotretinoin on quality of life and depressive symptoms

British Journal of Dermatology

Volumn 163, Issue 6, 2010, Pages 1323-1329

  McGrath, E J ^a   Lovell, C R ^a   Gillison, F ^b   Darvay, A ^a   Hickey, J R ^a   Skevington, S M ^c  

^a ROYAL UNITED HOSPITAL   (United Kingdom)

^b University of Bath   (United Kingdom)

^c University of Bath   (United Kingdom)

Author keywords

acne; depression; isotretinoin; quality of life; WHOQOL BREF

Indexed keywords

ADAPALENE; ISOTRETINOIN; LYMECYCLINE; MINOCYCLINE;

ACNE; ADOLESCENT; ADULT; ANTIBIOTIC THERAPY; ARTICLE; CENTER FOR EPIDEMIOLOGICAL STUDIES DEPRESSION SCALE; CHILD; CLINICAL TRIAL; COMMUNITY LIVING; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DRUG EFFECT; HUMAN; OUTCOME ASSESSMENT; OUTPATIENT; PRIORITY JOURNAL; PROSPECTIVE STUDY; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; RATING SCALE; SCHOOL CHILD; SCORING SYSTEM; SOCIAL ASPECT; TREATMENT DURATION; UNSPECIFIED SIDE EFFECT;

ACNE VULGARIS; ADOLESCENT; ADULT; ANTI-BACTERIAL AGENTS; DEPRESSION; DERMATOLOGIC AGENTS; FEMALE; HUMANS; ISOTRETINOIN; MALE; PREVALENCE; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 78649664248     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2010.10060.x     Document Type: Article

References (43)

1. Cordain L, Lindeberg S, Hurtado M, et al. Acne vulgaris: a disease of Western civilization. Arch Dermatol 2002; 138: 1584-90.
2. Cunliffe WJ, Gould DJ,. Prevalence of facial acne vulgaris in late adolescence and in adults. BMJ 1979; i: 1109-10.
3. Simpson N,. Effect of isotretinoin on the quality of life of patients with acne. Pharmacoeconomics 1994; 6: 108-13.
4. Mallon E, Newton JN, Klassen A, et al. The quality of life in acne: a comparison with general medical conditions using generic questionnaires. Br J Dermatol 1999; 140: 672-6.
5. Beattie PE, Lewis-Jones MS,. A comparative study of impairment of quality of life in children with skin disease and children with other chronic childhood diseases. Br J Dermatol 2006; 155: 145-51.
6. Mosam A, Vawda NB, Gordhan AH, et al. Quality of life issues for South Africans with acne vulgaris. Clin Exp Dermatol 2005; 30: 6-9.
7. Gupta MA, Gupta AK,. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol 1998; 139: 846-50.
8. Lamberg L,. Acne drug depression warnings highlight need for expert care. JAMA 1998; 279: 1057.
9. Bigby M, Stern RS,. Adverse reactions to isotretinoin. J Am Acad Dermatol 1988; 18: 543-52.
10. Acne, isotretinoin and depression. Drug Ther Bull 2003; 41: 76-8.
11. Chia CY, Lane W, Chibnall J, et al. Isotretinoin therapy and mood changes in adolescents with moderate to severe acne: a cohort study. Arch Dermatol 2005; 141: 557-60.
12. Wysowski DK, Pitts M, Beitz J,. An analysis of reports of depression and suicide in patients treated with isotretinoin. J Am Acad Dermatol 2001; 45: 515-19.
13. Jacobs DG, Deutsch NL, Brewer M,. Suicide, depression, and isotretinoin: is there a causal link? J Am Acad Dermatol 2001; 45: S168-75.
14. Jick SS, Kremers HM, Vasilakis-Scaramozza C,. Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide. Arch Dermatol 2000; 136: 1231-6.
15. Marqueling AL, Zane LT,. Depression and suicidal behavior in acne patients treated with isotretinoin: a systematic review. Semin Cutan Med Surg 2005; 24: 92-102.
16. Ng CH, Tam MM, Celi E, et al. Prospective study of depressive symptoms and quality of life in acne vulgaris patients treated with isotretinoin compared to antibiotic and topical therapy. Australas J Dermatol 2002; 43: 262-8.
17. Finlay AY, Khan GK,. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19: 210-16.
18. Motley RJ, Finlay AY,. Practical use of a disability index in the routine management of acne. Clin Exp Dermatol 1992; 17: 1-3.
19. Walker N, Lewis-Jones MS,. Quality of life and acne in Scottish adolescent schoolchildren: use of the Children's Dermatology Life Quality Index (CDLQI) and the Cardiff Acne Disability Index (CADI). J Eur Acad Dermatol Venereol 2006; 20: 45-50.
20. The WHOQOL Group. The World Health Organization Quality of Life Assessment (WHOQOL): development and general psychometric properties. Soc Sci Med 1998; 46: 1569-85.
21. The WHOQOL Group. The World Health Organization Quality of Life Assessment (WHOQOL): position paper from the World Health Organization. Soc Sci Med 1995; 41: 1403-9.
22. Agnihotri K, Awasthi S, Chandra H, et al. Validation of WHO QOL-BREF instrument in Indian adolescents. Indian J Pediatr 2010; 77: 381-6.
23. Skevington SM, Bradshaw J, Hepplewhite A, et al. How does psoriasis affect quality of life? Assessing an Ingram-regimen outpatient programme and validating the WHOQOL-100. Br J Dermatol 2006; 154: 680-91.
24. British Association of Dermatologists. Home page. Available at: (last accessed 5 September 2010).
25. The WHOQOL Group. Development of the World Health Organization WHOQOL-BREF quality of life assessment. Psychol Med 1998; 28: 551-8.
26. Skevington SM, Lotfy M, O'Connell KA,. WHOQOL Group. The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual Life Res 2004; 13: 299-310.
27. Skevington SM, McCrate FM,. Expecting a good quality of life in health. Assessing people with diverse diseases, conditions and health, using the WHOQOL-BREF. Health Expect (in press).
28. O'Brien SC, Lewis JB, Cunliffe WJ,. The Leeds revised acne grading system. J Dermatolog Treat 1998; 9: 215-20.
29. Prescott C, McArdle JJ, Hishinuma ES, et al. Prediction of major depression and dysthymia from CES-D scores among ethnic minority adolescents. J Am Acad Child Adolesc Psychiatry 1998; 37: 495-503.
30. Weissman MM, Orvaschel H, Padian N,. Children's symptom and social functioning self-report scales. Comparison of mothers' and children's reports. J Nerv Ment Dis 1980; 168: 736-40.
31. Long Foley K, Reed PS, Mutran EJ, DeVellis RF,. Measurement adequacy of the CES-D among a sample of older African-Americans. Psychiatry Res 2002; 109: 61-9.
32. Thombs BD, Hudson M, Schieir O, et al. Canadian Scleroderma Research Group. Reliability and validity of the Center for Epidemiologic Studies depression scale in patients with systemic sclerosis. Arthritis Rheum 2008; 59: 438-43.
33. Skevington SM, Wright A,. Changes in the quality of life of patients receiving antidepressant medication in primary care: validation of the WHOQOL-100. Br J Psychiatry 2001; 178: 261-7.
34. Kontaxakis VP, Skourides D, Ferentinos P, et al. Isotretinoin and psychopathology: a review. Ann Gen Psychiatry 2009; 8: 2.
35. O'Reilly KC, Shumake J, Gonzalez-Lima F, et al. Chronic administration of 13-cis-retinoic acid increases depression-related behavior in mice. Neuropsychopharmacology 2006; 31: 1919-27.
36. O'Reilly K, Bailey SJ, Lane MA,. Retinoid-mediated regulation of mood; possible cellular mechanisms. Exp Biol Med 2008; 233: 251-8.
37. Neumeister A, Young T, Stastny J,. Implications of genetic research on the role of serotonin in depression; emphasis on the serotonin type 1(A) receptor and the serotonin transporter. Psychopharmacology (Berl) 2004; 174: 512-24.
38. Bremner JD, Fani N, Ashraf A, et al. Functional brain imaging alterations in acne patients treated with isotretinoin. Am J Psychiatry 2005; 162: 983-91.
39. Azoulay L, Blais L, Koran G, et al. Isotretinoin and the risk of depression in patients with acne vulgaris; a case-cross-over study. J Clin Psychiatry 2008; 69: 526-32.
40. Dalgard F, Gieler U, Holm Jí, et al. Self-esteem and body satisfaction among late adolescents with acne: results from a population survey. J Am Acad Dermatol 2008; 59: 746-56.
41. Keymak Y, Taner F, Taner Y,. Comparison of depression, anxiety and life quality in acne vulgaris patients who were treated with either isotretinoin or topical agents. Int J Dermatol 2009; 48: 41-6.
42. Hahm BJ, Min SU, Yoon MY, et al. Changes of psychological parameters and their relationships by oral isotretinoin in acne patients. J Dermatol 2009; 36: 255-61.
43. Rehn LM, Meririnne E, Höök-Nikanne J, et al. Depressive symptoms and suicidal ideation during isotretinoin treatment: a 12-week follow-up study of male Finnish military conscripts. J Eur Acad Dermatol Venereol 2009; 23: 1294-7.